ArticleFrontiers in pharmacology2025
Efficient substructure feature encoding based on graph neural network blocks for drug-target interaction prediction.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Predicting drug-target interaction (DTI) is a crucial phase in drug discovery. The core of DTI prediction lies in appropriate representations learning of drug and target. Previous studies have confirmed the effectiveness of graph neural networks (GNNs) in drug compound feature encoding. However, these GNN-based methods do not effectively balance the local substructural features with the overall structural properties of the drug molecular graph. Methods: In this study, we proposed a novel model named GNNBlockDTI to address the current challenges. We combined multiple layers of GNN as a GNNBlock unit to capture the hidden structural patterns from drug graph within local ranges. Based on the proposed GNNBlock, we introduced a feature enhancement strategy to re-encode the obtained structural features, and utilized gating units for redundant information filtering. To simulate the essence of DTI that only protein fragments in the binding pocket interact with drugs, we provided a local encoding strategy for target protein using variant convolutional networks. Results: Experimental results on three benchmark datasets demonstrated that GNNBlockDTI is highly competitive compared to the state-of-the-art models. Moreover, the case study of drug candidates ranking against different targets affirms the practical effectiveness of GNNBlockDTI. The source code for this study is available at https://github.com/Ptexys/GNNBlockDTI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.